Cargando…
Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey
Randomized clinical trials (RCTs) with first- and second-generation drug-eluting stents (DESs) confirmed the superiority of coronary artery bypass surgery (CABG) in patients with multiple vessel disease. In spite of different DES designs, investigators in these trials used similar percutaneous coron...
Autores principales: | Rodriguez, Alfredo E., Pavlovsky, Hernán, Del Pozo, Juan Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145267/ https://www.ncbi.nlm.nih.gov/pubmed/27980442 http://dx.doi.org/10.4137/CMC.S40645 |
Ejemplares similares
-
Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
por: Kang, Se Hun, et al.
Publicado: (2017) -
Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease
por: Naito, Ryo, et al.
Publicado: (2015) -
Efficacy and safety of drug-eluting stenting compared with bypass grafting in diabetic patients with multivessel and/or left main coronary artery disease
por: Xin, Xiaojun, et al.
Publicado: (2019) -
Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
por: Chen, Xue, et al.
Publicado: (2020) -
Will coronary artery bypass grafting remain a standard of care for elderly patients with multivessel disease in the contemporary era?
por: Ono, M., et al.
Publicado: (2020)